Literature DB >> 8599863

High-dose 7-hydromethotrexate: acute toxicity and lethality in a rat model.

E Smeland1, O M Fuskevåg, K Nymann, J S Svendesn, R Olsen, S Lindal, R M Bremnes, J Aarbakke.   

Abstract

To elucidate mechanisms for methotrexate (MTX)-induced renal and hepatic toxicity, we investigated the acute effects of bolus plus continuous infusion of up to 0.4 g/kg 7-hydroxymethotrexate (7-OH-MTX) in the rat. We demonstrate for the first time in any species the occurrence of acute lethal toxicity within a few hours after 7-OH-MTX administration. Serum concentrations of 7-OH-MTX measured at the time of death were 1.4 mM (mean), about one-half of those achieved in some patients after infusion of high-dose MTX (HD-MTX) in the clinic. The data suggest an approximate LD50 (the dose lethal to 50% of the study population) of 0.3 g/kg and a steep dose/lethality curve for 7-OH-MTX. Moreover, acute renal and hepatic toxicity occurred as evidenced by severe morphological findings and increased serum levels of creatinine and liver transaminases. In all rats subjected to continuous infusion of 7-OH-MTX, yellow microscopic precipitations were apparent in the kidney tubules. Crystallization was also seen in bile ducts of the liver in some of the rats. These results further support that the formation of 7-OH-MTX is disadvantageous and that reported attempts to prevent its formation during MTX treatment are warranted.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8599863     DOI: 10.1007/s002800050406

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  53 in total

1.  Incidence of drug-related deaths secondary to high-dose methotrexate and citrovorum factor administration.

Authors:  D D Von Hoff; J S Penta; L J Helman; M Slavik
Journal:  Cancer Treat Rep       Date:  1977-07

Review 2.  Methods in testing interrelationships between excretion of drugs via urine and bile.

Authors:  C Fleck; H Bräunlich
Journal:  Pharmacol Ther       Date:  1984       Impact factor: 12.310

Review 3.  High-dose methotrexate: a critical reappraisal.

Authors:  S P Ackland; R L Schilsky
Journal:  J Clin Oncol       Date:  1987-12       Impact factor: 44.544

4.  Removal of methotrexate, leucovorin, and their metabolites by combined hemodialysis and hemoperfusion.

Authors:  M V Relling; F B Stapleton; J Ochs; D P Jones; W Meyer; I W Wainer; W R Crom; C P McKay; W E Evans
Journal:  Cancer       Date:  1988-09-01       Impact factor: 6.860

5.  Prolongation of rat cardiac allograft survival by donor pretreatment. Screening of antineoplastic drugs.

Authors:  A Soots; P Häyry
Journal:  Transplantation       Date:  1978-05       Impact factor: 4.939

6.  A simple preparation of the methotrexate metabolites 7-hydroxymethotrexate and 4-deoxy-4-amino-N10-methylpteroic acid.

Authors:  D A Cairnes; W E Evans
Journal:  Ther Drug Monit       Date:  1983       Impact factor: 3.681

7.  Acute hepatotoxicity after high-dose methotrexate administration to rats.

Authors:  R M Bremnes; E Smeland; N E Huseby; T J Eide; J Aarbakke
Journal:  Pharmacol Toxicol       Date:  1991-08

8.  Comparative study on the pharmacokinetics of 7-hydroxy-methotrexate after administration of methotrexate in the dose range of 0.5-33.6 g/m2 to children with acute lymphoblastic leukemia.

Authors:  J D Borsi; E Sagen; I Romslo; P J Moe
Journal:  Med Pediatr Oncol       Date:  1990

9.  The effects of diltiazem on methotrexate-induced nephrotoxicity.

Authors:  G Deray; D Khayat; P Cacoub; R Bourbouze; L Musset; A Baumelou; C Jacquillat; C Jacobs
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

10.  Clinical use of thymidine as a rescue agent from methotrexate toxicity.

Authors:  J L Grem; S A King; J M Sorensen; M C Christian
Journal:  Invest New Drugs       Date:  1991-08       Impact factor: 3.850

View more
  7 in total

1.  High dose methotrexate chemotherapy: pharmacokinetics, folate and toxicity in osteosarcoma patients.

Authors:  Laila Holmboe; Anders M Andersen; Lars Mørkrid; Lars Slørdal; Kirsten Sundby Hall
Journal:  Br J Clin Pharmacol       Date:  2012-01       Impact factor: 4.335

2.  Severe bone marrow suppression due to methotrexate toxicity following aceclofenac-induced acute kidney injury.

Authors:  Robin George Manappallil; Durga Prasan; Jayameena Peringat; Illolil Kuniyil Biju
Journal:  BMJ Case Rep       Date:  2018-06-05

Review 3.  Saffron nephroprotective effects against medications and toxins: A review of preclinical data.

Authors:  Batool Zarei; Sepideh Elyasi
Journal:  Iran J Basic Med Sci       Date:  2022-04       Impact factor: 2.532

4.  Comparative Metabolism of Batracylin (NSC 320846) and N-acetylbatracylin (NSC 611001) Using Human, Dog, and Rat Preparations In Vitro.

Authors:  Joseph M Covey; Joel M Reid; Sarah A Buhrow; Mary Kuffel; Chad Walden; Holger Behrsing; Matthew M Ames
Journal:  J Drug Metab Toxicol       Date:  2016-05-08

5.  Evaluating the Disposition of a Mixed Aldehyde Oxidase/Cytochrome P450 Substrate in Rats with Attenuated P450 Activity.

Authors:  Rachel D Crouch; Ryan D Morrison; Frank W Byers; Craig W Lindsley; Kyle A Emmitte; J Scott Daniels
Journal:  Drug Metab Dispos       Date:  2016-03-02       Impact factor: 3.922

6.  Nimesulide increases the aldehyde oxidase activity of humans and rats.

Authors:  Lei Zhou; Xiao-Yan Pang; Xiang-Yu Hou; Lu Liu; Zi-Tao Guo; Xiao-Yan Chen
Journal:  Acta Pharmacol Sin       Date:  2020-01-08       Impact factor: 6.150

7.  Geraniol Averts Methotrexate-Induced Acute Kidney Injury via Keap1/Nrf2/HO-1 and MAPK/NF-κB Pathways.

Authors:  Nancy S Younis; Heba S Elsewedy; Tamer M Shehata; Maged E Mohamed
Journal:  Curr Issues Mol Biol       Date:  2021-10-24       Impact factor: 2.976

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.